[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Lu et al., 2016 - Google Patents

Ras conformational ensembles, allostery, and signaling

Lu et al., 2016

View PDF
Document ID
5833250122455403763
Author
Lu S
Jang H
Muratcioglu S
Gursoy A
Keskin O
Nussinov R
Zhang J
Publication year
Publication venue
Chemical reviews

External Links

Snippet

Ras proteins are classical members of small GTPases that function as molecular switches by alternating between inactive GDP-bound and active GTP-bound states. Ras activation is regulated by guanine nucleotide exchange factors that catalyze the exchange of GDP by …
Continue reading at drive.google.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases

Similar Documents

Publication Publication Date Title
Lu et al. Ras conformational ensembles, allostery, and signaling
Soriano et al. The crossroads between RAS and RHO signaling pathways in cellular transformation, motility and contraction
Ni et al. Emerging roles of allosteric modulators in the regulation of protein‐protein interactions (PPIs): A new paradigm for PPI drug discovery
Chakrabarti et al. Comparison of the conformations of KRAS isoforms, K-Ras4A and K-Ras4B, points to similarities and significant differences
Jang et al. Membrane-associated Ras dimers are isoform-specific: K-Ras dimers differ from H-Ras dimers
Teng et al. Selective and noncovalent targeting of RAS mutants for inhibition and degradation
Bier et al. The molecular tweezer CLR01 stabilizes a disordered protein–protein interface
Organ et al. Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer
Lee et al. Proximity-directed labeling reveals a new rapamycin-induced heterodimer of FKBP25 and FRB in live cells
Park et al. Molecular dynamics analysis of binding of kinase inhibitors to WT EGFR and the T790M mutant
Sayyed-Ahmad et al. Computational equilibrium thermodynamic and kinetic analysis of K-Ras dimerization through an effector binding surface suggests limited functional role
Watson et al. Discovery, development, and cellular delivery of potent and selective bicyclic peptide inhibitors of Grb7 cancer target
Liu et al. Reactivities of the front pocket N-terminal cap cysteines in human kinases
Ahmad Mokhtar et al. A complete survey of RhoGDI targets reveals novel interactions with atypical small GTPases
Zhang et al. Calmodulin (CaM) activates PI3Kα by targeting the “soft” CaM-binding motifs in both the nSH2 and cSH2 domains of p85α
Senyuz et al. Mechanistic differences of activation of Rac1P29S and Rac1A159V
Zhang et al. Ca2+-dependent switch of calmodulin interaction mode with tandem IQ motifs in the scaffolding protein IQGAP1
Wang et al. Interaction of calmodulin with the cSH2 domain of the p85 regulatory subunit
Yelland et al. Stabilization of the ras: Pde6d complex is a novel strategy to inhibit ras signaling
Regmi et al. Phosphorylation-dependent conformations of the disordered carboxyl-terminus domain in the epidermal growth factor receptor
Milroy et al. The renaissance of Ras
Höing et al. Recognition of a flexible protein loop in taspase 1 by multivalent supramolecular tweezers
Gurumoorthy et al. Disordered domain shifts the conformational ensemble of the folded regulatory domain of the multidomain oncoprotein c-Src
Pagba et al. KRAS inhibitor that simultaneously inhibits nucleotide exchange activity and effector engagement
Garcia-Viloca et al. Molecular insights into the regulation of 3-phosphoinositide-dependent protein kinase 1: modeling the interaction between the kinase and the pleckstrin homology domains